Ruxolitinib Appears Effective as Treatment of Steroid-Refractory GVHD Targeted Oncology 1:09 3 years ago 196 Скачать Далее
Ruxolitinib Appears Promising as Treatment of Chronic Graft-Versus-Host Disease Targeted Oncology 1:06 4 years ago 242 Скачать Далее
Case 3: Ruxolitinib for Steroid-Refractory Acute GVHD Targeted Oncology 4:03 4 years ago 108 Скачать Далее
Case 2: Ruxolitinib for Steroid-Refractory Acute GVHD Targeted Oncology 5:18 4 years ago 144 Скачать Далее
Management of acute and chronic GvHD VJHemOnc – Video Journal of Hematology & HemOnc 4:26 4 years ago 889 Скачать Далее
Overcoming the Challenges of Acute and Chronic GVHD PeerView Oncology 56:36 2 years ago 2 074 Скачать Далее
REACH2: What patients with steroid-refractory acute GvHD respond best to ruxolitinib? GvHD Hub 4:58 4 years ago 171 Скачать Далее
An update on the use of FMT for the treatment of steroid- and ruxolitinib-resistant acute GvHD VJHemOnc – Video Journal of Hematology & HemOnc 3:51 1 year ago 64 Скачать Далее
Graft-versus-Host Disease: Advances in Prevention and Treatment BMT InfoNet 58:10 1 year ago 1 876 Скачать Далее
Ruxolitinib and ibrutinib: the future for GvHD treatment? VJHemOnc – Video Journal of Hematology & HemOnc 2:29 6 years ago 1 281 Скачать Далее
Initial, Steroid-Refractory, and Novel Treatment Options for GVHD Targeted Oncology 5:29 4 years ago 47 Скачать Далее
REACH3 study: Should ruxolitinib become SoC for steroid-dependent or refractory chronic GvHD? GvHD Hub 4:46 3 years ago 212 Скачать Далее
Clinical Perspective: Integrating Ruxolitinib into the Treatment of Acute GVHD MedEdOTG 7:41 4 years ago 50 Скачать Далее
Steroid-Refractory GvHD: Treatment With JAK Inhibitors Targeted Oncology 2:42 4 years ago 64 Скачать Далее
Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease PeerView Oncology 56:28 1 year ago 198 Скачать Далее
